XML 17 R5.htm IDEA: XBRL DOCUMENT v3.25.2
CONDENSED CONSOLIDATED STATMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Jan. 31, 2024   224,728      
Beginning balance at Jan. 31, 2024 $ 326,396 $ 2 $ 1,821,216 $ (236) $ (1,494,586)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon the exercise of stock options (in shares)   673      
Issuance of common stock upon the exercise of stock options 2,129   2,129    
Repurchases and retirement of common stock (in shares)   (1,446)      
Repurchases and retirement of common stock (19,721)       (19,721)
Issuance of common stock upon the vesting and settlement of restricted stock units (in shares)   4,880      
Issuance of common stock upon the vesting and settlement of restricted stock units (4)   (4)    
Issuance of common stock under employee share purchase plan (in shares)   654      
Issuance of common stock under employee share purchase plan 8,866   8,866    
Stock-based compensation expense 110,704   110,704    
Net unrealized (losses) gains on marketable securities 38     38  
Foreign currency translation adjustments (580)     (580)  
Net loss (135,911)       (135,911)
Ending balance (in shares) at Jul. 31, 2024   229,489      
Ending balance at Jul. 31, 2024 291,917 $ 2 1,942,911 (778) (1,650,218)
Beginning balance (in shares) at Apr. 30, 2024   228,036      
Beginning balance at Apr. 30, 2024 319,897 $ 2 1,880,675 (2,472) (1,558,308)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon the exercise of stock options (in shares)   321      
Issuance of common stock upon the exercise of stock options 1,044   1,044    
Repurchases and retirement of common stock (in shares)   (1,446)      
Repurchases and retirement of common stock (19,721)       (19,721)
Issuance of common stock upon the vesting and settlement of restricted stock units (in shares)   2,578      
Issuance of common stock upon the vesting and settlement of restricted stock units 0        
Stock-based compensation expense 61,192   61,192    
Net unrealized (losses) gains on marketable securities 1,413     1,413  
Foreign currency translation adjustments 281     281  
Net loss (72,189)       (72,189)
Ending balance (in shares) at Jul. 31, 2024   229,489      
Ending balance at Jul. 31, 2024 291,917 $ 2 1,942,911 (778) (1,650,218)
Beginning balance (in shares) at Jan. 31, 2025   232,888      
Beginning balance at Jan. 31, 2025 $ 227,523 $ 2 2,059,848 (3,851) (1,828,476)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon the exercise of stock options (in shares) 593 593      
Issuance of common stock upon the exercise of stock options $ 2,073   2,073    
Repurchases and retirement of common stock (in shares)   (2,992)      
Repurchases and retirement of common stock (43,398)       (43,398)
Issuance of common stock upon the vesting and settlement of restricted stock units (in shares)   5,105      
Issuance of common stock upon the vesting and settlement of restricted stock units 0        
Issuance of common stock under employee share purchase plan (in shares)   751      
Issuance of common stock under employee share purchase plan 7,746   7,746    
Stock-based compensation expense 113,876   113,876    
Net unrealized (losses) gains on marketable securities 120     120  
Foreign currency translation adjustments 4,994     4,994  
Net loss (88,378)       (88,378)
Ending balance (in shares) at Jul. 31, 2025   236,345      
Ending balance at Jul. 31, 2025 224,556 $ 2 2,183,543 1,263 (1,960,252)
Beginning balance (in shares) at Apr. 30, 2025   235,220      
Beginning balance at Apr. 30, 2025 236,304 $ 2 2,118,447 1,955 (1,884,100)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon the exercise of stock options (in shares)   239      
Issuance of common stock upon the exercise of stock options 816   816    
Repurchases and retirement of common stock (in shares)   (1,958)      
Repurchases and retirement of common stock (27,792)       (27,792)
Issuance of common stock upon the vesting and settlement of restricted stock units (in shares)   2,844      
Issuance of common stock upon the vesting and settlement of restricted stock units 0        
Stock-based compensation expense 64,280   64,280    
Net unrealized (losses) gains on marketable securities (944)     (944)  
Foreign currency translation adjustments 252     252  
Net loss (48,360)       (48,360)
Ending balance (in shares) at Jul. 31, 2025   236,345      
Ending balance at Jul. 31, 2025 $ 224,556 $ 2 $ 2,183,543 $ 1,263 $ (1,960,252)